Dr. Adnan M. Subei, DO

Dr. Subei practices at Dallas Pediatric Neurology Associates - HOPD in Dallas, Texas.

Dr. Subei's NPI, 1962722876, was assigned on June 3, 2010. Dr. Subei graduated from LECOM at Seton Hill - Greensburg in 2008. Dr. Subei holds Texas license R1302.

Dr. Subei's primary practice is Dallas Pediatric Neurology Associates - HOPD, at 8390 Lyndon B Johnson Fwy, Dallas, TX 75243.

Dr. Subei's primary practice is Dallas Pediatric Neurology Associates - HOPD in Dallas, Texas. Dr. Subei is also affiliated with Medical City Dallas Hospital. The medical group on file is Texas Health Physicians Group. Dmand AI also links Dr. Subei to 4 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Subei practices, 8 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Subei's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Subei is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Subei is licensed in Texas.

Dmand AI lists acute mini-stroke (TIA), carpal tunnel syndrome, encephalopathy, fibromyalgia and chronic pain, hereditary polyneuropathy, lower back pain, migraine and chronic headache and multiple sclerosis among the conditions Dr. Subei treats.

CMS data shows 1,806 Medicare services from Dr. Subei across 16 procedure codes in 2024, for 320 Medicare patients. Medicare paid $86,498 for them.

CMS counts 320 Medicare patients who saw Dr. Subei in 2024. The largest group is 65 to 74, with 126 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Subei's median patient age at 61, with 63% women.

In 2024, Dr. Subei wrote 457 Medicare Part D claims for 133 patients. 86% of them were for generic drugs. CMS names the drug for 280 of them, across 12 drugs with 11 or more claims each, at $115,973 in total drug cost. In 2023, CMS named 335 claims across 14 drugs.

Dr. Subei accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Subei as offering telehealth.

Dmand AI links 9 papers to Dr. Subei, published from 2022 to 2025. 2025 was the busiest year, with 2. The most frequent topics are Multiple Sclerosis, Antibodies, Monoclonal, Humanized and Diplopia. Dr. Subei has published most often in Curr Opin Ophthalmol. Dr. Subei's most frequent co-authors are Eric Eggenberger, DO, Hesham Ahmed Abboud, MD and Brandi Janece Baker, MD.

Dmand AI links Dr. Subei to 1 clinical trial. Conditions studied include Multiple Sclerosis, Relapsing-Remitting and Multiple Sclerosis. Open Payments lists research payments to Dr. Subei that name 2 trials.

CMS Open Payments shows 895 general payments to Dr. Subei from 46 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 82% of the total. EMD Serono, Inc. paid the most, $132,431. It also lists 27 research payments totaling $13,657 from 2019 to 2025, naming 2 clinical trials.

Dr. Subei graduated from LECOM at Seton Hill - Greensburg in 2008. Dr. Subei is a member of AAN and AOA.

Dr. Subei is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.